Adaptive Designs in Clinical Drug Development —An Executive Summary of the PhRMA Working Group

DOI 15 References

Bibliographic Information

Other Title
  • 医薬品の臨床開発におけるアダプティブ・デザイン‐米国研究製薬工業協会ワーキング・グループのエグゼクティブ・サマリー邦訳‐

Search this article

Description

A PhRMA Working Group on adaptive clinical trial designs has been formed to investigate and facilitate opportunities for wider acceptance and usage of adaptive designs and related methodologies. A White Paper summarizing the findings of the group is currently in preparation. This article is an Executive Summary of that full White Paper; it summarizes the findings and recommendations of the group. Logistic, operational, procedural, and statistical challenges associated with adaptive designs are addressed. Three particular areas where adaptive designs can likely be utilized beneficially are discussed: dose finding, seamless Phase II/III trial designs, and sample size reestimation.

Journal

References(15)*help

See more

Keywords

Details 詳細情報について

  • CRID
    1390282680345417216
  • NII Article ID
    130004541349
  • DOI
    10.3999/jscpt.40.303
  • ISSN
    18828272
    03881601
  • Text Lang
    ja
  • Data Source
    • JaLC
    • Crossref
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top